Evidence map›Paper›PMID 42262106›Full record

ArticlemBio2026

Active removal of inhibitory components drives the flagellar type 3 secretion-specificity switch.

Fabienne F V Chevance, Dara Niketic, DingBang Wu, Carl Ty Mellor, David F Blair, Sherwood R Casjens, Miki Kinoshita, Keiichi Namba, Tohru Minamino, Kelly T Hughes

Abstract read
In one paragraph

Article in mBio, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors.

Fabienne F V ChevanceSchool of Biological Sciences, The University of Utah, Salt Lake City, Utah, USA.ORCID 0000-0003-2997-3466
Dara NiketicSchool of Biological Sciences, The University of Utah, Salt Lake City, Utah, USA.
DingBang WuSchool of Biological Sciences, The University of Utah, Salt Lake City, Utah, USA.
Carl Ty MellorSchool of Biological Sciences, The University of Utah, Salt Lake City, Utah, USA.
David F BlairSchool of Biological Sciences, The University of Utah, Salt Lake City, Utah, USA.
Sherwood R CasjensSchool of Biological Sciences, The University of Utah, Salt Lake City, Utah, USA.ORCID 0000-0002-1213-7130
Miki KinoshitaGraduate School of Frontier Biosciences, The University of Osaka, Suita, Osaka, Japan.
Keiichi NambaGraduate School of Frontier Biosciences, The University of Osaka, Suita, Osaka, Japan.
Tohru MinaminoGraduate School of Frontier Biosciences, The University of Osaka, Suita, Osaka, Japan.ORCID 0000-0002-8175-1951
Kelly T HughesSchool of Biological Sciences, The University of Utah, Salt Lake City, Utah, USA.ORCID 0000-0001-5344-0972

Funding

Coupling gene regulation to flagellar morphogenesisR01GM056141 · NIGMS · UNIVERSITY OF WASHINGTON · PI HUGHES, KELLY T · 1998 to 2023
$8.3M
TRAINING PROGRAM IN GENETICST32GM007464 · NIGMS · UNIVERSITY OF UTAH · PI GRUNWALD, DAVID J., STANFIELD, GILLIAN · 1985 to 2020
$6.1M
Salmonella type III secretion: substrate targeting and injectisome assemblyR56AI184395 · NIAID · UNIVERSITY OF UTAH · PI HUGHES, KELLY T · 2024 to 2024
$728k
NIAID NIH HHS R56 AI184395NIGMS NIH HHS R01 GM056141NIGMS NIH HHS T32 GM007464
6 · The paper itself

Abstract

Type 3 secretion (T3S) systems assemble bacterial nanomachines, including the flagellum and virulence-associated injectisomes, by exporting distinct classes of substrates in a defined temporal order. In both systems, completion of an early assembly intermediate triggers an irreversible switch from early to late substrate secretion. In the flagellar system, this switch is controlled by the secreted molecular ruler FliK, which acts on the core T3S component FlhB, but the molecular mechanism governing this transition has remained unclear. Here, we show that removal of two components, Fluke and the cleaved C-terminal domain of FlhB (FlhB IMPORTANCE: Type III secretion (T3S) systems build complex bacterial nanomachines, including the flagellum and virulence-associated injectisomes, by exporting distinct classes of substrates in a defined temporal order. How these systems switch secretion specificity during assembly has remained a long-standing question. We demonstrate that the flagellar T3S-specificity switch requires removal of two inhibitory components that actively maintain the apparatus in an early secretion state. Their FliK-dependent ejection irreversibly triggers the transition to late substrate export, revealing that secretion switching is controlled by active inhibitory regulation rather than passive sensing of assembly completion. These results define a molecular mechanism for hierarchical control in bacterial secretion systems and provide insights likely relevant to other T3S nanomachines.

Indexed as

Bacterial ProteinsFlagellaMembrane ProteinsSalmonella typhimuriumType III Secretion SystemsGene Expression Regulation, BacterialBacterial ProteinsFlhB protein, BacteriaFliK protein, BacteriaMembrane ProteinsType III Secretion Systemsflagellananomachinesecretionsecretion-specificity switchtype III secretion

Identifiers

PMID42262106
PMCPMC13344023

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.